Actively Recruiting
Comparing the Morrow eProgressive Electronic Adjustable Lenses to Standard Progressive Addition Lenses for Visual and Physical Comfort in Presbyopia
Led by Morrow Eyewear · Updated on 2026-10-16
50
Participants Needed
3
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Presbyopia is an age-related condition that reduces the eyes ability to focus on nearby objects, usually starting around age 45. Traditional progressive addition lenses PALs help correct this but have limitations like narrow viewing zones, peripheral distortion, and requiring unnatural head movements, which can affect comfort and safety. This study evaluates a new electronically adjustable progressive lens called the Morrow eProgressive, which dynamically adapts its optical zones, comparing its functional performance to standard PALs. The study uses a randomized, open-label, crossover design involving about 50 adults aged 45 or older who have presbyopia with a minimum 1.75 addition. Participants wear each type of glassesthe Morrow eProgressive and traditional PALsfor three weeks in random order. The Morrow eProgressive is a CE-marked device that actively adapts focus electronically to provide a wider, clearer visual field. Participants wear the assigned spectacles exclusively for day-to-day activities during each 3-week period, with exceptions for sports or specific occasions. During the study, researchers measure eye and head movements during reading tasks, stair descent performance, and visual comfort through questionnaires. Outcomes include reduction in head gain, stair descent time, walking cadence variability, near visual acuity questionnaire scores, and subjective lens preference. Participants adherence to the wearing schedule is monitored to assess real-world usability. The total study period includes two 3-week wearing phases, allowing comparison of each lens type within the same individuals.
CONDITIONS
Brief Title
Evaluation of Functional Superiority of the Morrow eProgressive
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here